Authors: DEMARIA D STEVENSON JP MITCHELL E ROSE L REDLINGER M KUNZ K NYHART E STORNIOLO AM ODWYER PJ

Citation: D. Demaria et al., PHASE-I TRIAL OF THE DIARYLSULFONYLUREA LY295501 ADMINISTERED ON A WEEKLY X-3 SCHEDULE, Annals of oncology, 9, 1998, pp. 438-438

Authors: BEALE P JUDSON I REES C TRIGO J NYHART E WOLF L WALKER R MOORE S HANWELL J

Citation: P. Beale et al., PHASE-I TRIAL OF THE DIARYLSULFONYLUREA LY295501 ADMINISTERED ORALLY ONCE-DAILY FOR 5 DAYS EVERY 28 DAYS, Annals of oncology, 9, 1998, pp. 439-439

Authors: DIAB S BAKER SD HAMMOND L VILLALONA M ECKHARDT SG TINU C WEISS G KRAYNAK M AYLESWORTH C SMITH L RODRIGUEZ G DRENGLER R PATIL R SIU L ROTHENBERG M SMETZER L NYHART E STORNIOLO AM VONHOFF D ROWINSKY E

Citation: S. Diab et al., PHASE-I AND PHARMACOKINETIC (PK) STUDY OF THE DIARYLSULFONYLUREA LY295501 ADMINISTERED AS A SINGLE ORAL DOSE WEEKLY FOR 3 WEEKS EVERY 4 WEEKS, Annals of oncology, 9, 1998, pp. 440-440

Authors: KASSAHUN K MATTIUZ E NYHART E OBERMEYER B GILLESPIE T MURPHY A GOODWIN M TUPPER D CALLAGHAN JT LEMBERGER L

Citation: K. Kassahun et al., DISPOSITION AND BIOTRANSFORMATION OF THE ANTIPSYCHOTIC AGENT OLANZAPINE IN HUMANS, Drug metabolism and disposition, 25(1), 1997, pp. 81-93